美迪西建立了100多种细胞株用于细胞水平测定。
Medicilon owns over 100 different cancer cell lines for cell-based assay.
这些发现表明测定肿瘤细胞内这两类蛋白的水平可帮助预测患者对微管蛋白抑制剂抗癌药的治疗效果。
Their findings suggest that testing tumor cells for levels of these proteins could help to predict patient response to antitubulin agents.
方法应用郭峰法测定原发性高血脂症患者红细胞免疫功能指标,同步测定血脂水平,并进行统计分析。
Methods the indexes of erythrocyte immunologic function and the blood lipid content in patients with primary hyperlipoidemia were determined by Guofeng methods.
应用推荐